Fibroblast Growth Factor Receptor 3 Interacts with and Activates TGFβ-Activated Kinase 1 Tyrosine Phosphorylation and NFκB Signaling in Multiple Myeloma and Bladder Cancer-Reference-Cited by-同舟云学术

Fibroblast Growth Factor Receptor 3 Interacts with and Activates TGFβ-Activated Kinase 1 Tyrosine Phosphorylation and NFκB Signaling in Multiple Myeloma and Bladder Cancer

Published:2014-01-23 Issue:1 Volume:9 Page:e86470
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Salazar Lisa,Kashiwada Tamara,Krejci Pavel,Meyer April N.,Casale Malcolm,Hallowell Matthew,Wilcox William R.,Donoghue Daniel J.,Thompson Leslie Michels

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference85 articles.

1. Cancer statistics, 2013;R Siegel;CA Cancer J Clin,2013

2. Iyer G, Milowsky MI (2012) Fibroblast growth factor receptor-3 in urothelial tumorigenesis. Urol Oncol.

3. The t(4;14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies;A Kalff;Blood Cancer J,2012

4. Many multiple myelomas: making more of the molecular mayhem;M Chesi;Hematology Am Soc Hematol Educ Program,2011

5. Molecular heterogeneity of multiple myeloma: pathogenesis, prognosis, and therapeutic implications;AL Herve;J Clin Oncol,2011

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel anti-FGFR1 monoclonal antibody OM-RCA-01 exhibits potent antitumor activity and enhances the efficacy of immune checkpoint inhibitors in lung cancer models;Immuno-Oncology and Technology;2024-09

2. Associations of TRAF2 (rs867186), TAB2 (rs237025), IKBKB (rs13278372) Polymorphisms and TRAF2, TAB2, IKBKB Protein Levels with Clinical and Morphological Features of Pituitary Adenomas;Cancers;2024-07-10

3. Pathways Affected by Falcarinol-Type Polyacetylenes and Implications for Their Anti-Inflammatory Function and Potential in Cancer Chemoprevention;Foods;2023-03-11

4. Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential;Pharmacology & Therapeutics;2022-08

5. New developments in the biology of fibroblast growth factors;WIREs Mechanisms of Disease;2022-02-09